Document 0747 DOCN M9550747 TI Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells. DT 9505 AU Atwood WJ; Tornatore CS; Traub R; Conant K; Drew PD; Major EO; Laboratory of Molecular Medicine and Neuroscience, National; Institute of Neurological Disorders and Stroke, Bethesda,; Maryland 20892. SO AIDS Res Hum Retroviruses. 1994 Oct;10(10):1207-11. Unique Identifier : AIDSLINE MED/95151357 AB In vitro, HIV-1 infection of human fetal glial cells initiates a noncytopathic, productive infection that results in a long-term persistence during which the viral genome remains latent. The cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) reactivate HIV-1 gene expression in these cells, leading to production of infectious virus. Here we show that treatment of human fetal glial cells with TNF-alpha and IL-1 beta increase expression of the reporter gene chloramphenicol acetyltransferase (CAT) when placed under the control of the HIV-1 5' LTR. We also show that treatment of human fetal glial cells with TNF-alpha leads to increased binding of the nuclear transcription factor NF-kappa B (p50/p65) to a consensus kappa B-binding site present in the HIV-1 5'LTR. Our results suggest that TNF-alpha stimulation of HIV-1 gene expression in primary cultures of human fetal glial cells is mediated by an increase in binding of NF-kappa B (p50/p65) to the HIV-1 LTR. This is the first report documenting NF-kappa B-binding activity in primary cultures of human fetal glial cells. DE Base Sequence Binding Sites Brain/METABOLISM Cell Nucleus/METABOLISM Cytokines/PHARMACOLOGY Fetus Gene Expression/*DRUG EFFECTS Genome, Viral Human HIV Long Terminal Repeat HIV-1/DRUG EFFECTS/GENETICS/*PHYSIOLOGY Molecular Sequence Data Neuroglia/DRUG EFFECTS/*METABOLISM/VIROLOGY NF-kappa B/*BIOSYNTHESIS/METABOLISM Oligonucleotide Probes Transfection Tumor Necrosis Factor/*PHARMACOLOGY Virus Latency JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).